Bristol-Myers Squibb CEO Chris Boerner detailed the pharmaceutical giant’s bundle of recent acquisitions in a Monday interview with CNBC’s Jim Cramer, and indicated the company is in a transformative stage. “We are writing the next chapter of this company,” Boerner said. “And we’ve got real financial strength that has enabled us to go and actually … Read more
It’s not being talked about enough. This market move off the November lows and the Fed pivot — signaling an end to the central bank’s rate-hiking cycle — is one of the most astonishing and satisfying I have seen in 43 years of investing. In nine weeks, we blew through price targets on so many … Read more
Here’s our Club Mailbag email [email protected] — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. This week’s question: Hi, I have 18 stocks. My top … Read more
The first week of 2024 is officially in the books – and with it, the end of a nine-week winning streak on Wall Street. The S & P 500 dropped about 1.5% during the holiday-shortened trading week. The Nasdaq was the worst performer this week, losing more than 3% as the Magnificent Seven stocks and … Read more
Another Wall Street analyst has thrown their support behind Coterra Energy , adding to Jim Cramer’s belief that the oil and gas producer is a stock to watch in the new year. Bank of America on Friday upgraded Coterra to buy from a hold-equivalent rating, becoming the fourth research firm in less than a month … Read more
CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the last few months. He told investors to keep an eye on these moves in advance of the JPMorgan health care conference next week. “I know that drug companies are tough to own in … Read more
CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care conference in San Francisco. Taking place from Monday to Thursday, the conference is one of the year’s largest gatherings of major industry CEOs where they reveal earnings guidance and updates on clinical trial research. “The … Read more
Meta Platforms ‘ savvy use of artificial intelligence and untapped potential in business messaging are reasons why we see more upside ahead for the stock in 2024. Meta reached a 52-week high of $361.90 per share on the second to last trading day of 2023. The stock nearly tripled last year and was the second-best … Read more
Everybody likes a comeback story. Constellation Brands ‘ stock has stalled, leaving long-time shareholders like us frustrated. However, the Mexican beer powerhouse has an opportunity to redeem itself with Friday’s quarterly earnings print. Constellation is set to report its fiscal 2024 third quarter before the opening bell. Analysts expect revenue to grow 2.5% to $2.5 … Read more
CNBC’s Jim Cramer on Thursday predicted the market will continue to broaden through January, suggesting the “Magnificent Seven” tech stocks may take a back seat on Wall Street. He said he’s had “an explosion of positive ideas from every nook and cranny of the market” since the new year started. According to Cramer, the market … Read more
